Tag: Cancer: Ovarian
Intraperitoneal Chemotherapy Ups Ovarian Cancer Outcomes
However, only 41 percent of suitable candidates actually receive the therapy
Novel Pharmacological Activity for R-Ketorolac in Ovarian Cancer
R-enantiomer enriched in peritoneal fluids, inhibits peritoneal cell GTPase activity
Worse Survival With Chemo Dose Reduction in Ovarian Cancer
Lower average relative dose intensity linked to worse overall and ovarian cancer-specific survival
Benefits for Surgery Before Chemo in Advanced Ovarian CA
Appears to raise quality of life without shortening survival
Multimodal Strategy Improves Ovarian Cancer Detection
Screening using risk of ovarian cancer algorithm linked to increased number of screen-detected iEOCs
Survival Improving for Women With Ovarian Cancer
Women diagnosed today 50 percent less likely to die than they were in the 1970s
Review Examines Salpingectomy Alone for Cutting Ovarian CA Risk
Recent evidence suggests fallopian tube epithelium is origin of most high-grade serous cancers
Breast, Ovarian CA Risk Varies With BRCA Mutation Location
Nonsense-mediated decay mutations linked to differential breast or ovarian cancer risk
Recommendations Issued for Prevention of Ovarian Cancer
Oral contraceptive use, tubal sterilization, and genetic testing and counseling recommended
SGO: Promising Research in Treatment of Ovarian Cancer
Experimental vaccine and cancer drug each slow disease progression, researchers find
